UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Investigational hypoxia-activated prodrugs: Making sense of future development Journal article
Current Drug Targets, 2019,Volume: 20,Issue: 6,Page: 668-678
Authors:  Su,Min Xia;  Zhang,Le Le;  Huang,Zhang Jian;  Shi,Jia Jie;  Lu,Jin Jian
Favorite |  | TC[WOS]:3 TC[Scopus]:4 | Submit date:2021/03/02
Dna Alkylating Agents  Hypoxia-activated Prodrug  Patient Selection  Reductase Activity  Targeted Drugs  Topoisomerase Ii Inhibitors  
Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy Journal article
SMALL, 2018,Volume: 15,Issue: 4
Authors:  Zhimei He;  Yunlu Dai;  Xiangli Li;  Dan Guo;  Yijing Liu;  Xiaolin Huang;  Jingjing Jiang;  Sheng Wang;  Guizhi Zhu;  Fuwu Zhang;  Lisen Lin;  Jun‐Jie Zhu;  Guocan Yu;  Xiaoyuan Chen
Favorite |  | TC[WOS]:55 TC[Scopus]:61 | Submit date:2020/05/13
Banoxantrone  Cascade Therapy  Hypoxia-activated Prodrugs  Nanoscale Metal-organic Frameworks  Photodynamic Therapy  
Hybrid Nanomedicine Fabricated from Photosensitizer‐Terminated Metal–Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia‐Activated Cascade Chemotherapy Journal article
small, 2018,Volume: 15,Issue: 4
Authors:  Zhimei He;  Yunlu Dai;  Xiangli Li;  Dan Guo;  Yijing Liu;  Xiaolin Huang;  Jingjing Jiang;  Sheng Wang;  Guizhi Zhu;  Fuwu Zhang;  Lisen Lin;  Jun‐Jie Zhu;  Guocan Yu;  Xiaoyuan Chen
Favorite |  | TC[WOS]:0 TC[Scopus]:61 | Submit date:2019/01/28
Banoxantrone  Cascade Therapy  Hypoxia‐activated Prodrugs  Nanoscale Metal–organic Frameworks  Photodynamic Therapy